Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company's product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for the treatment of community-acquired bacterial pneumonia. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, hospital-acquired bacterial pneumonia, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Nabriva Therapeutics plc Ordinary Shares Ireland.
Nabriva Therapeutics plc Ordinary Shares Ireland business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Nabriva Therapeutics plc Ordinary Shares Ireland are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Nabriva Therapeutics plc Ordinary Shares Ireland , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Nabriva Therapeutics plc Ordinary Shares Ireland including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Nabriva Therapeutics plc Ordinary Shares Ireland and all latest updates of the company are provided.
The 2025 version of Nabriva Therapeutics plc Ordinary Shares Ireland report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Facts
2.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Geographic Locations
2.3 Nabriva Therapeutics plc Ordinary Shares Ireland- Subsidiaries and Affiliates
2.4 Nabriva Therapeutics plc Ordinary Shares Ireland- Business Divisions
2.5 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Nabriva Therapeutics plc Ordinary Shares Ireland Strategic Analysis Review
3.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Strategies
3.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Company Outlook Statement
3.3 Nabriva Therapeutics plc Ordinary Shares Ireland- SWOT Analysis
3.3.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Strengths
3.3.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Weaknesses
3.3.3 Nabriva Therapeutics plc Ordinary Shares Ireland- Potential Opportunities
3.3.4 Nabriva Therapeutics plc Ordinary Shares Ireland- Potential Threats
3.4 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Competitors
4. Business Description of the Company
4.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Business Overview
4.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Operations by Segment
5 Products and Services Details
5.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Products
5.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Service Areas
5.3 Nabriva Therapeutics plc Ordinary Shares Ireland- Key Brands
6 Company Developments
6.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Company History
6.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Latest Developments
7 Financial Analysis
7.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Income Statements
7.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Balance Sheet
7.3 Nabriva Therapeutics plc Ordinary Shares Ireland- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Nabriva Therapeutics plc Ordinary Shares Ireland- Direct Competitors
8.2 Nabriva Therapeutics plc Ordinary Shares Ireland- Competitor Financial Ratios comparison
8.3 Nabriva Therapeutics plc Ordinary Shares Ireland- Competitor Stock Charts Comparison
8.4 Nabriva Therapeutics plc Ordinary Shares Ireland- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
